These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10544300)

  • 41. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
    Chen R; Yu Y; Dong X
    J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.
    Lubrano C; Sciarra F; Spera G; Petrangeli E; Toscano V; Rombola N; Palleschi F; Palma E; Di Silverio F
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):683-7. PubMed ID: 1373303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia.
    Brochu M; Bélanger A
    Prostate; 1987; 11(1):33-40. PubMed ID: 2443905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Estrogen and estrogen receptors in benign prostatic hyperplasia].
    Wu JQ; Gao X
    Zhonghua Nan Ke Xue; 2002; 8(3):212-4. PubMed ID: 12478848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
    Ellem SJ; Risbridger GP
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
    Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
    J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of stroma in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ
    Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia.
    Stege R; Carlström K
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):357-62. PubMed ID: 1376613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.
    Levine AC; Kirschenbaum A; Gabrilove JL
    Mt Sinai J Med; 1997 Jan; 64(1):20-5. PubMed ID: 8997072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.
    Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z
    Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate.
    Royuela M; de Miguel MP; Bethencourt FR; Sánchez-Chapado M; Fraile B; Arenas MI; Paniagua R
    J Endocrinol; 2001 Mar; 168(3):447-54. PubMed ID: 11241176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone and Benign Prostatic Hyperplasia.
    Rastrelli G; Vignozzi L; Corona G; Maggi M
    Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.